van den Heuvel-Eibrink MM - Search Results

1

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

Aalbers AM, Calado RT, Young NS, Zwaan CM, Wu C, Kajigaya S, Coenen EA, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Kuijpers TW, Reinhardt D, Trka J, Zimmermann M, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM. Aalbers AM, et al. Leukemia. 2013 Aug;27(8):1786-9. doi: 10.1038/leu.2013.57. Epub 2013 Feb 21. Leukemia. 2013. PMID: 23426163 Free PMC article. No abstract available.

2

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

3

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. van den Heuvel-Eibrink MM, et al. Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. doi: 10.5414/cpp38094. Int J Clin Pharmacol Ther. 2000. PMID: 10739113 Review.

4

MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, Slater RM, Smit EM, van Noesel MM, van der Holt B, Schoester M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 Mar;15(3):398-405. doi: 10.1038/sj.leu.2402027. Leukemia. 2001. PMID: 11237063

5

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Kuijpers M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 May;15(5):855-6. doi: 10.1038/sj.leu.2402112. Leukemia. 2001. PMID: 11368449 No abstract available.

6

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, van der Holt B, Vossebeld PJ, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Blood. 2001 Jun 1;97(11):3605-11. doi: 10.1182/blood.v97.11.3605. Blood. 2001. PMID: 11369657 Free article.

7

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496. Leukemia. 2002. PMID: 11986944

8

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

Stam RW, van den Heuvel-Eibrink MM, den Boer ML, Ebus ME, Janka-Schaub GE, Allen JD, Pieters R. Stam RW, et al. Leukemia. 2004 Jan;18(1):78-83. doi: 10.1038/sj.leu.2403168. Leukemia. 2004. PMID: 14574327

9

The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphoma.

Huang L, Lequin M, Pieters R, van den Heuvel-Eibrink MM. Huang L, et al. Pediatr Blood Cancer. 2007 Apr;48(4):468-72. doi: 10.1002/pbc.20813. Pediatr Blood Cancer. 2007. PMID: 16514610

10

Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.

van Beek RD, Bezemer DD, Meijerink JP, de Muinck Keizer-Schrama SM, Haas OA, Te Winkel L, Pieters R, van den Heuvel-Eibrink M. van Beek RD, et al. Leukemia. 2006 May;20(5):879-80. doi: 10.1038/sj.leu.2404161. Leukemia. 2006. PMID: 16525499 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page